NOVO NORDISK A S (NVO) Form 6-K — Oct 6, 2026
Novo Nordisk reported continued execution of its DKK 15 billion share repurchase programme, buying 245,000 B shares per day at average prices near DKK 249-253 in the week through 2 October 2026. Under the tranche initiated 6 May 2026, the company has repurchased 21,845,000 B shares for DKK 6.45 billion, and DKK 10.25 billion in total since the programme began on 4 February 2026.
Key figures
- Total shares
- 4465000000
- Ytd value dkk
- 10247270869
- Treasury shares
- 50644876
- Tranche limit dkk
- DKK 11,200,000,010.45 (6 May 2026 to 1 February 2027)
- Tranche value dkk
- 6447270879
- Programme size dkk
- DKK 15 billion over 12 months beginning 4 February 2026
- Ytd average price dkk
- 279.95
- Ytd repurchases shares
- 36604179
- Treasury pct of share capital
- 1.1%
- Shares repurchased under tranche
- 21845000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.